Medication adherence to oral cancer therapy: The promising role of the pharmacist.
Medication adherence to oral cancer therapy is a critical component to achieving optimal patient outcomes. As the US population ages, growing numbers of patients will be prescribed oral cancer therapy regimens, highlighting the need for innovative and scalable solutions. Clinical pharmacists offer tremendous promise to help patients improve their adherence to oral cancer therapy. Moreover, addition of oral chemotherapy to Centers for Medicare & Medicaid Services (CMS) medication adherence quality measures has the potential to improve care and result in better therapeutic outcomes with fewer costs for patients and payers. Future research is needed to test the use of pharmacist-managed interventions to improve adherence to oral cancer therapy.
School of Pharmacy, University of Pittsburgh, USA.
Maria A
MA
Felton
Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, USA.
G J
GJ
van Londen
Division of Geriatric Medicine, Department of Medicine, University of Pittsburgh, USA zam12@pitt.edu.
Zachary A
ZA
Marcum
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D055118:Medication Adherence; D054539:Medication Therapy Management / Q000639:trends; D009062:Mouth Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D010595:Pharmacists / Q000639:trends; D024382:Professional Role
D000970:Antineoplastic Agents
Medication adherence; oral cancer therapy; pharmacy practice